Special Issue "Non-invasive Biopharmaceutical/Vaccine Delivery Systems and Formulation Strategies"
Deadline for manuscript submissions: closed (20 August 2023) | Viewed by 2639
Interests: drug delivery; drug/vaccine formulation; personal protective equipment; antimicrobial technology
2. Medical Research Center for Bioreaction to Reactive Oxygen Species and Biomedical Science Institute, School of Medicine, Graduate School, Kyung Hee University, Seoul 02447, Korea
Interests: virus-like particle vaccines and other vaccine formulations against respiratory virus and parasite infections; vaccine delivery
Special Issues, Collections and Topics in MDPI journals
The COVID-19 pandemic has posed a serious threat to global health and provided invaluable lessons moving forward. Some of the major concerns and challenges associated with the pandemic management have been identified: 1) cold-chain transportation/storage/distribution, 2) the limited shelf life/thermal stability of vaccines, and 3) needle-based administration of vaccines by healthcare providers. Consequently, research on innovative biopharmaceuticals, including vaccine technology, has gained remarkable attention as a means of addressing the issues, possessing the potential to improve our preparedness for future pandemics and the development of highly effective biologic therapies.
This Special Issue focuses on developing a universally applicable, efficient, and non-invasive biopharmaceutical/vaccine delivery system and formulations. The extensive potential of highly effective, long-term, thermally stable, liquid or solid-type drugs arises from their dose-sparing effect, the ability to stockpile, the lack of any need for cold-chain storage/transportation, and self-administration. With the continued risk of COVID-19, we consider the present to be an appropriate time to evaluate what has been achieved in relevant fields so far and propose a research agenda for many years to come.
This Special Issue should be of immediate interest to a diverse readership, including those interested in non-invasive drug/vaccine technology for a wide range of biopharmaceuticals (i.e., genes, peptides, proteins, virus, cells, etc.).
For the purpose of this Special Issue, the submission of any original research articles and reviews on non-invasive biopharmaceuticals/vaccines (oral, transdermal, and intranasal) will be highly appreciated. Research areas may include (but not limited to) the following: drug/vaccine manufacturing, stability, formulation, administration routes, delivery system, and dose-sparing technology.
We look forward to receiving your contributions.
Prof. Dr. Hyo-Jick Choi
Prof. Dr. Fu-Shi Quan
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- biopharmaceutical/vaccine delivery
- biopharmaeutical/vaccine formulation
- vaccine development
- transdermal delivery
- intranasal delivery
- oral delivery
- long-term thermal stability
- cold-chain free
- solid biopharmaceutical/vaccine